Alzheimer Disease

Researchers Begin Study Of Possible Vaccine

Published in Vaccine Weekly, September 19th, 2001

Researchers are hoping a vaccine they are about to study in a human trial will prevent or reduce the onset of Alzheimer disease.

Pivotal Research Centers are enrolling patients for the 15-month experiment. Scott Gardner, executive director of the Arizona chapter of the Alzheimer's Association, said two recent studies have shown that the vaccine appears to work in mice. Gardner said the vaccine trial in humans now gives hope to victims of the disease and their families.

"It's extremely, extremely promising and, yes, it's an attainable goal,'' he said.

At least 25 people with mild-to-moderate Alzheimer disease will be chosen for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2001-09-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry